肾移植受者对第三剂SARS-CoV-2 mRNA BNT162b2疫苗的抗体和T细胞反应。 - Suppr

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients.

作者信息

Bertrand Dominique, Hamzaoui Mouad, Lemée Veronique, Lamulle Julie, Laurent Charlotte, Etienne Isabelle, Lemoine Mathilde, Lebourg Ludivine, Hanoy Mélanie, Le Roy Frank, Nezam Dorian, Farce Fabienne, Plantier Jean-Christophe, Boyer Olivier, Guerrot Dominique, Candon Sophie

机构信息

Department of Nephrology, Transplantation and Hemodialysis, Rouen University Hospital, Rouen, France.

出版信息

Kidney Int. 2021 Dec;100(6):1337-1340. doi: 10.1016/j.kint.2021.09.014. Epub 2021 Oct 4.

DOI:10.1016/j.kint.2021.09.014

PMID:34619232

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8489274/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e696/8489274/663d6f449160/gr1_lrg.jpg

相似文献

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients.肾移植受者对第三剂SARS-CoV-2 mRNA BNT162b2疫苗的抗体和T细胞反应。

Kidney Int. 2021 Dec;100(6):1337-1340. doi: 10.1016/j.kint.2021.09.014. Epub 2021 Oct 4.

Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.肾移植受者对 SARS-CoV-2 mRNA 疫苗的抗体反应：一项前瞻性队列研究。

Clin Microbiol Infect. 2021 Aug;27(8):1173.e1-1173.e4. doi: 10.1016/j.cmi.2021.04.028. Epub 2021 May 3.

Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。

Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely.未接触过病毒的肾移植受者对SARS-CoV-2 mRNA疫苗BNT162b2的体液反应降低：虽不令人恐慌，但应予以高度重视。

Am J Transplant. 2021 Aug;21(8):2909. doi: 10.1111/ajt.16710. Epub 2021 Jun 18.

Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2.肾移植受者对新型冠状病毒mRNA疫苗BNT162b2的血清学反应取决于既往对新型冠状病毒的接触情况。

Am J Transplant. 2021 Nov;21(11):3806-3807. doi: 10.1111/ajt.16726. Epub 2021 Jul 10.

Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.肾移植受者首次接种mRNA新冠疫苗后抗SARS-CoV-2抗体反应较弱。

Kidney Int. 2021 Jun;99(6):1487-1489. doi: 10.1016/j.kint.2021.03.014. Epub 2021 Mar 26.

Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.肾移植受者中mRNA-1273和BNT162b2新冠病毒mRNA疫苗免疫原性的比较

Transpl Int. 2022 Jan 4;35:10026. doi: 10.3389/ti.2021.10026. eCollection 2021.

Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.接受2剂mRNA-1273新型冠状病毒疫苗的肾移植受者中免疫接种率较低。

Kidney Int. 2021 Jun;99(6):1498-1500. doi: 10.1016/j.kint.2021.04.005. Epub 2021 Apr 20.

Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19.有新冠病毒疾病既往史的肾移植受者在接种第一剂基于信使核糖核酸的新冠病毒疫苗后产生强烈抗体反应。

Am J Transplant. 2021 Nov;21(11):3808-3810. doi: 10.1111/ajt.16764. Epub 2021 Jul 23.

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm.未接触过病毒的肾移植受者对mRNA新冠病毒BNT162b2疫苗的体液免疫反应降低：无需惊慌。

Am J Transplant. 2021 Aug;21(8):2908. doi: 10.1111/ajt.16687. Epub 2021 Jun 4.

引用本文的文献

Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1-2 Clinical Trial.鼻内候选疫苗Mambisa和肌肉注射疫苗Abdala作为新冠康复者加强剂量的安全性和免疫原性：一项1-2期随机临床试验

Vaccines (Basel). 2024 Sep 1;12(9):1001. doi: 10.3390/vaccines12091001.

Immunogenicity and Safety of the Three-Dose COVID-19 Vaccine Regimen in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis.接受肾脏替代治疗患者的三剂新冠疫苗接种方案的免疫原性和安全性：一项系统评价和荟萃分析

Kidney Dis (Basel). 2024 Jan 19;10(2):107-117. doi: 10.1159/000536308. eCollection 2024 Apr.

Patterns of Circulating Cytokines and Vascular Markers' Response in the Presence of COVID-19 in Kidney Transplant Recipients Compared with Non-Transplanted Patients.与非移植患者相比，COVID-19 对肾移植受者循环细胞因子和血管标志物反应的影响模式。

Viruses. 2023 Oct 28;15(11):2166. doi: 10.3390/v15112166.

Cellular immune response of SARS-CoV-2 vaccination in kidney transplant recipients: a systematic review and meta-analysis.肾移植受者中 SARS-CoV-2 疫苗接种的细胞免疫反应：系统评价和荟萃分析。

Front Immunol. 2023 Jul 26;14:1220148. doi: 10.3389/fimmu.2023.1220148. eCollection 2023.

Booster effect of the third dose of SARS-CoV-2 mRNA vaccine in Japanese kidney transplant recipients.第三剂 SARS-CoV-2 mRNA 疫苗对日本肾移植受者的增强效应。

Sci Rep. 2023 Jun 20;13(1):9976. doi: 10.1038/s41598-023-36998-1.

Optimizing COVID-19 Vaccination Strategy in Pediatric Kidney Transplant Recipients: Humoral and Cellular Response to SARS-CoV-2 mRNA Vaccination.优化儿科肾移植受者的 COVID-19 疫苗接种策略：对 SARS-CoV-2 mRNA 疫苗接种的体液和细胞反应。

Transpl Int. 2023 May 12;36:11153. doi: 10.3389/ti.2023.11153. eCollection 2023.

Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients.肾移植受者中同源和异源 COVID-19 疫苗接种方案引起的可比较细胞和体液免疫。

Front Immunol. 2023 Mar 31;14:1172477. doi: 10.3389/fimmu.2023.1172477. eCollection 2023.

Immunogenicity of SARS-CoV-2 Vaccine in Kidney Transplant Recipients: A Cross-Sectional Study in Korea.韩国一项横断面研究：肾移植受者中 SARS-CoV-2 疫苗的免疫原性。

J Korean Med Sci. 2023 Feb 6;38(5):e22. doi: 10.3346/jkms.2023.38.e22.

Efficacy and safety of booster vaccination against SARS-CoV-2 in dialysis and renal transplant patients: systematic review and meta-analysis.透析和肾移植患者接种 SARS-CoV-2 加强疫苗的疗效和安全性：系统评价和荟萃分析。

Int Urol Nephrol. 2023 Apr;55(4):791-802. doi: 10.1007/s11255-023-03471-x. Epub 2023 Feb 1.

Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients.肾移植受者在第二次接种疫苗后较长间隔时间接种第三剂 SARS-CoV-2 mRNA 疫苗的体液和细胞免疫应答及安全性。

Front Immunol. 2022 Nov 30;13:1050211. doi: 10.3389/fimmu.2022.1050211. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献